title: Rifabutin appears to be a promising agent for combination treatment of AIDS-related toxoplasma encephalitis.
authors.forename: D
authors.initials: D
authors.lastname: Schürmann
authors.forename: M P
authors.initials: MP
authors.lastname: Grobusch
authors.forename: B
authors.initials: B
authors.lastname: Ruf
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000469:parasitology*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D017828:Rifabutin / Q000008:administration & dosage / Q000627:therapeutic use*; D016781:Toxoplasmosis, Cerebral / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D017828:Rifabutin